Public Health Emergency - Leading a Nation Prepared
Healthcare facilities, long-term care facilities, dialysis centers, federally qualified health centers, correctional facilities, and urgent care centers, can provide monoclonal antibody (mAb) treatments. Subcutaneous administration can be done by healthcare providers in an office setting or at the patient homes.
Monoclonal antibody (mAb) treatments may be given to high-risk COVID-19 outpatients and as a post-exposure prophylaxis. mAb treatments can help save lives and reduce stress on hospitals and healthcare facilities by reducing the number of patients who develop serious forms of COVID-19. Use the planning resources below to make important decisions about becoming a mAb administration site, including resource considerations, product ordering, tracking, and reimbursement.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages